Schuldschein market hits record lows as margins tumble
B. Braun, the German medical and pharmaceutical devices firm, set a new Schuldschein record for low margins, launching a €150m triple tranche transaction amid increasingly aggressive pricing conditions.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
- ✔ 4,000 annual insights
- ✔ 700+ notes and long-form analyses
- ✔ 4 capital markets databases
- ✔ Daily newsletters across markets and asset classes
- ✔ 2 weekly podcasts